Universal Health (UHS) Tops Q3 EPS by 85c, Beats on Revenue; Offers FY25 Guidance
Universal Health (NYSE: UHS) reported Q3 EPS of $5.69, $0.85 better than the analyst estimate of $4.84. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.34 billion.
GUIDANCE:
Universal Health sees FY2025 EPS of $21.50-$22.10, versus the consensus of $20.80. Universal Health sees FY2025 revenue of $17.31-17.45 billion, versus the consensus of $17.23 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
